These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20960876)

  • 1. [Estrogen and progesterone receptors].
    Sawada T; Sakayori N
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():799-802. PubMed ID: 20960876
    [No Abstract]   [Full Text] [Related]  

  • 2. [Estrogen receptor (ER), progesterone receptor (PR)].
    Sawada T; Sakayori N
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():762-4. PubMed ID: 16149634
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of immunohistochemical markers in the diagnosis of carcinoma of the breast].
    Bussolati G
    Minerva Chir; 1988 Sep; 43(18 Suppl):5-7. PubMed ID: 3226595
    [No Abstract]   [Full Text] [Related]  

  • 4. Equivalency of RT-PCR and immunohistochemistry: fact or factoid.
    Badve S
    Breast Cancer Res Treat; 2009 Jul; 116(1):145-7. PubMed ID: 18787946
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estrogen and progesterone receptors in breast cancer].
    Sonoo H
    Nihon Rinsho; 2000 Apr; 58 Suppl():146-53. PubMed ID: 11025988
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunohistochemical markers as predictive tools for breast cancer.
    Walker RA
    J Clin Pathol; 2008 Jun; 61(6):689-96. PubMed ID: 18037665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
    Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA
    Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved breast cancer biomarker detection through a simple, high frequency, low cost external proficiency testing program.
    Hung T; Wolber R; Garratt J; Kalloger S; Gilks CB
    Pathology; 2010 Dec; 42(7):637-42. PubMed ID: 21080872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell receptors and proliferation markers in breast cancer].
    Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
    Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer is heterogeneous.
    Guinebretiere JM
    J Clin Oncol; 2009 Jun; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract]   [Full Text] [Related]  

  • 11. [Loss of hormonal receptors expression from primary breast carcinoma to axillary lymph node metastases].
    Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):540-4. PubMed ID: 14756058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogen and progesterone receptors].
    Sawada T; Kato T; Kimura T; Kameoka S
    Nihon Rinsho; 1999 Dec; 57 Suppl():583-5. PubMed ID: 10778197
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytologic diagnosis of low grade endometrial stromal sarcoma by staining for estrogen and progesterone receptors.
    Reich O; Pickel H; Regauer S
    Acta Cytol; 2002; 46(4):790-2. PubMed ID: 12146057
    [No Abstract]   [Full Text] [Related]  

  • 15. Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?
    Arnould L; Coudert B; Fumoleau P
    J Clin Oncol; 2009 Jun; 27(16):2733; author reply 2734-5. PubMed ID: 19380432
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of steroid receptors with histopathologic characteristics in breast carcinoma.
    Bhatavdekar JM; Trivedi SN; Shah NG; Karelia NH; Patel DD; Giri DD; Patel TB
    Neoplasma; 1988; 35(4):413-23. PubMed ID: 3185838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
    von Minckwitz G; Kaufmann M
    Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinctive biology of pleomorphic lobular carcinoma of the breast.
    Moe RE; Anderson BO
    J Surg Oncol; 2005 May; 90(2):47-50. PubMed ID: 15844193
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognostic factors in breast cancer and their consequences for therapeutic decisions].
    Graeff H; Jänicke F
    Chirurg; 1992 Jun; 63(6):461-8. PubMed ID: 1643982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.